 "NU_CMS_HERO_IMAGE_143_16x9_desktop")
Numan is a UK digital health company treating the conditions that shape how long, and how well, people live. We combine clinical care, behavioural coaching, pharmacy, and diagnostics in one service, across obesity and weight loss, men's health, women's health, and blood testing.
Over 800,000 people have come to Numan to improve their health. Our clinical service is regulated by the Care Quality Commission and our pharmacy is registered with the General Pharmaceutical Council. Our research is presented at the world's leading obesity congresses. You can read our published research here.
Founded in 2018 by Sokratis Papafloratos, Numan is based in London.
Founding year: 2018
Total funding raised: $120m
Employees: 400+
Patients: over 800,000
For any media enquiries, please contact our PR team: [email protected]
The Numan press office inbox is monitored during office hours (8am - 6pm) Monday - Friday. If you do contact us outside of office hours, we’ll do our best to get back to you as soon as possible the next working day.
Important: This email is for media use only. Please do not use it for customer service enquiries as these will not be addressed here.
| Contact | |
|---|---|
| Harriet Allner Policy & PR Director | [email protected] |
| For speaking enquiries: | [email protected] |
| For sponsorship & partnership enquiries: | [email protected] |
| For clinical research enquiries | [email protected] |
| For regulatory or legal enquiries | [email protected] |
| For customer care enquiries | [email protected] |
 "NU_IMAGE_131_1x1_master")
Our latest announcements, campaign launches, and patient stories. For embargoed releases or supporting assets, email [email protected].
Seat Anxiety Index: press release
World Cup 'semi' campaign: press release
Patient story: Dianne
Patient story: Debbie
Cost of needlephobia: press release
Canary ED campaign: press release
State of Obesity Report 2025: press release
Half of overweight Brits cancel plans over fears they won't fit into seats
Features Numan's survey data highlighting how "seat anxiety" leads millions of Brits to avoid major events like weddings or flights. It includes expert insight from Zoe regarding the importance of sustainable support alongside medication.
Sad truth why nan, 56, always ate at the same three restaurants for years
A detailed feature on Debbie, who overcame "seat anxiety" and lost weight through the Numan programme, with the article using her story to highlight the broader issue of social withdrawal due to weight.
From 'posture pouches' to smoking - 5 hidden causes of belly fat
An expert-led piece featuring Zoe’s advice on reducing belly fat, emphasising the impact of cutting back on ultra-processed foods and increasing fibre intake.
Why we crave junk food – and how to stop fighting your biology
Food cravings aren’t a lack of willpower – they’re shaped by hormones, habit and your brain’s reward system. Registered dietitian Zoe Griffiths explains why we crave junk food and how to respond with strategy, not self-criticism, alongside satisfying recipes from TV chef Rosemary Shrager designed to steady appetite and deliver real pleasure.
GLP-1s and supplements: What experts want you to know
In the Vogue feature, Zoe Griffiths provides expert guidance on optimizing health while taking GLP-1 medications. She highlights the importance of maintaining adequate protein and fiber intake, while cautioning against specific supplements that may interfere with medication absorption.
Numan rises to England’s semi with cheeky OOH campaign
In the LBB feature, Numan's reactive out-of-home campaign, created by Wonderhood Makers, uses England's World Cup semi-final to land one unmissable message: 'Don't stop at a semi'. Dr Zak Zafrani notes that erectile dysfunction is one of the most common yet least discussed men's health issues, and that it's treatable.
Numan can provide expert commentary across obesity and weight management, men's and women's health, digital healthcare, AI in clinical care, and health policy. To arrange an interview, contact [email protected].
 "Soks")
Founder and CEO
Sokratis Papafloratos
Comment on: digital health, company strategy, the future of healthcare.
Sokratis founded Numan in 2018 to build a digital health service that treats chronic conditions properly rather than one prescription at a time. He has spent over 20 years building technology companies in the UK and Europe.
:cv(1784110213898) "jk")
Chief Medical Strategy Officer
Dr James King, MBBS, PhD
Comment on: AI in healthcare, clinical strategy, digital health innovation.
James shapes the clinical strategy behind Numan's healthspan mission, including the application of AI in healthcare. A University of Cambridge-trained researcher, he holds an honorary research position at Durham University and previously built digital health products now used in the care of over three million NHS patients.
 "Daniebrightman")
Clinical Director
Danielle Brightman, MPharm
Comment on: pharmacy, medication safety, responsible prescribing.
A qualified pharmacist with over 15 years of experience across the NHS and private services, Danielle leads Numan's clinical product team. She is a leading voice in the global conversation on clinical product as well as a regular commentator on digital innovation, responsible prescribing, and medicines safety.
 "zoegriffiths")
VP of Behavioural Medicine
Zoe Griffiths, BSc, RD
A registered dietitian for over 20 years and a SCOPE-certified obesity practitioner, Zoe previously worked on the global science team at WeightWatchers International and led behavioural medicine at Allurion Technologies. She serves on the committee for the British Dietetic Association Obesity Specialist Group.
:cv(1769526688413) "BeckyJones_015")
Head of Clinical Research
Dr Rebecca Jones, BSc, MPh, PhD
Rebecca holds a PhD from the University of Cambridge and has spent 13 years in digital healthcare and clinical research. She has over 30 peer-reviewed publications on obesity, behaviour change, and long-term weight health.
:cv(1773652505441) "DrZak")
GP and Men's Health Specialist
Dr Zak Zafrani, MBChB (Hons), MRCGP, DPD, FRSPH
Zak works across metabolic health and sports medicine, including testosterone replacement therapy (TRT) in athletes and platelet-rich plasma (PRP) in recovery. He received the 2025 Emerging Scholars Award from the Androgen Society.
 "NU_IMAGE_132_1x1_master")
Every year, Numan surveys the country on how it understands obesity: whether people see it as a disease or a choice, what they make of medications like Wegovy and Mounjaro, and where stigma still shapes the conversation. The report has become a benchmark for tracking how public attitudes are changing.
Our 2025 findings show the first recorded decline in the belief that obesity is a personal choice, down from 57% to 44%, alongside a clear gender divide in how men and women view treatment.
 "NU_IMAGE_006_1x1_master")
Numan brings its clinical evidence and frontline experience to the questions that the government is trying to answer: how obesity should be treated, how weight loss medication should be supplied safely, and how digital healthcare should be regulated as it becomes part of everyday care.
We contribute formal evidence to the bodies shaping health policy and ground our recommendations and insight in our own research. Our economic modelling with health economists set out what obesity costs the country and how the UK can harness new developments in digital, medical, and pharmacological arenas to help address the health and economic impact of obesity.
Updated:
Founder and CEO
Sokratis Papafloratos
Comment on: digital health, company strategy, the future of healthcare.
Sokratis founded Numan in 2018 to build a digital health service that treats chronic conditions properly rather than one prescription at a time. He has spent over 20 years building technology companies in the UK and Europe.
Chief Medical Strategy Officer
Dr James King, MBBS, PhD
Comment on: AI in healthcare, clinical strategy, digital health innovation.
James shapes the clinical strategy behind Numan's healthspan mission, including the application of AI in healthcare. A University of Cambridge-trained researcher, he holds an honorary research position at Durham University and previously built digital health products now used in the care of over three million NHS patients.
Clinical Director
Danielle Brightman, MPharm
Comment on: pharmacy, medication safety, responsible prescribing.
A qualified pharmacist with over 15 years of experience across the NHS and private services, Danielle leads Numan's clinical product team. She is a leading voice in the global conversation on clinical product as well as a regular commentator on digital innovation, responsible prescribing, and medicines safety.
VP of Behavioural Medicine
Zoe Griffiths, BSc, RD
A registered dietitian for over 20 years and a SCOPE-certified obesity practitioner, Zoe previously worked on the global science team at WeightWatchers International and led behavioural medicine at Allurion Technologies. She serves on the committee for the British Dietetic Association Obesity Specialist Group.
Head of Clinical Research
Dr Rebecca Jones, BSc, MPh, PhD
Rebecca holds a PhD from the University of Cambridge and has spent 13 years in digital healthcare and clinical research. She has over 30 peer-reviewed publications on obesity, behaviour change, and long-term weight health.
GP and Men's Health Specialist
Dr Zak Zafrani, MBChB (Hons), MRCGP, DPD, FRSPH
Zak works across metabolic health and sports medicine, including testosterone replacement therapy (TRT) in athletes and platelet-rich plasma (PRP) in recovery. He received the 2025 Emerging Scholars Award from the Androgen Society.
 "NU_CMS_HERO_IMAGE_143_16x9_desktop")
 "NU_IMAGE_020_1x1_master")
 "01_AppPromo_Mob_01png")
 "01_AppPromo_Desktop_01")